Led by Tyler Berzin, MD, researchers at Weston-based Cleveland Clinic Florida emailed surveys to 330 gastroenterologists around the country. They received 124 responses. Dr. Berzin is a consultant for Wision AI and Medtronic.
Five key findings:
1. Eighty-five percent of respondents open to using AI said they believed computer-assisted polyp detection, or CADe, could improve endoscopic performance.
2. Seventy-six percent of GI specialists would trust CADe to increase detection rates for potentially cancerous adenomatous polyps.
3. Fifty-seven percent of respondents expressed willingness to use computer-aided diagnosis, or CADx, as part of a “diagnose and leave” approach to treating hyperplastic polyps believed to be benign.
4. GI physicians with less than 15 years of post-fellowship experience showed “more optimism regarding AI’s ability,” researchers said. Less experience was also linked to the belief that CADe would improve endoscopist satisfaction.
5. Respondents said the top three barriers to AI in clinical gastroenterology are:
- Cost (75 percent)
- The potential for physicians to become dependent on the technology (63 percent)
- Added time to complete colonoscopies (60 percent)
“There is strong interest among U.S. gastroenterologists about AI assistance during endoscopic procedures, and they believe it would improve their performance, specifically with regard to CADe polyp detection,” the study concludes. “As CADe and CADx tools continue to develop at a rapid pace, we expect that adoption of CADe for colonoscopy in the U.S. gastroenterology community will outpace adoption of CADx.”
Click here to access the study.
More articles on surgery centers:
Top priorities for ASC leaders today and in 2021: 7 key trends
Viewpoint: An otolaryngologist’s perspective on COVID-19
9.4% of healthcare providers will ‘definitely’ change careers — 5 survey insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
